Dengue Outbreaks in Abidjan: Seroprevalence and Cocirculating of Three Serotypes in 2017

Authors

  • Yahaya Sylla National Reference Laboratory, Epidemic Virus Department, Institut Pasteur de Côte d'Ivoire, Ivory Coast
  • Maxime Kouao Diane Unit of Viruses of the Nervous System, Institut Pasteur de Côte d'Ivoire, Ivory Coast
  • Valey Edgard Adjogoua Unit of Viruses of the Nervous System, Institut Pasteur de Côte d'Ivoire, Ivory Coast
  • Herve Kadjo Unit of Viruses of the Respiratory System, Institut Pasteur de Côte d'Ivoire, Ivory Coast
  • Mireille Dosso Institut Pasteur de Côte d'Ivoire Direction, Ivory Coast

DOI:

https://doi.org/10.59096/osir.v14i3.262527

Keywords:

dengue virus, outbreaks, surveillance, National Reference Laboratory, epidemiology, Abidjan

Abstract

Dengue fever is a major public health problem in the world, because it is especially endemic in the tropical and subtropical areas. Arbovirus infection is less well documented in African countries. We aimed to assess the distribution of patients in the dengue epidemic and the seroprevalence of different serotypes of the circulating dengue virus. A retrospective study included analyses of human blood samples sent to the National Reference Laboratory for diagnosis during dengue infection outbreak. Samples were screened by IgM capture ELISA (MAC-ELISA) or by RT-PCR. Of the 2,849 serum samples from suspected dengue cases, 2,297 (80.6%) were from Abidjan. The seroprevalence of dengue was (15.1%) during this epidemic. The seroprevalence of dengue virus serotypes in cocirculation was predominated by DENV-2 with 189 cases (6.6%), followed by DENV-3 77 cases (2.7%), and DENV-1 14 cases (0.5%). The seroprevalence in children was 8.7% compared to 19.0% in adults. The age group of 16 to less than 45 years accounted for 54.0% of total positive cases. In addition, positive peak was observed in July (28.3%) and Abidjan East was the most affected locality. The increasing trend of serotypes of the dengue virus cocirculation suggests that Abidjan is becoming a hyperendemic state from an endemic one.

References

Phoutrides EK, Coulibaly MB, George CM, Sacko A, Traore S, Bessoff K, et al. Dengue virus seroprevalence among febrile patients in Bamako, Mali: results of a 2006 surveillance study. Vector Borne Zoonotic Dis. 2011;11(11): 1479-85. doi:10.1089/vbz.2011.0622.

Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760. doi:10.1371/journal.pntd.0001760.

Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10(2):100-3.

Reiter P. Yellow fever and dengue: a threat to Europe? Euro Surveill. 2010;15(10):19509.

Gupta E, Dar L, Narang P, Srivastava VK, Broor S. Serodiagnosis of dengue during an outbreak at a tertiary care hospital in Delhi. Indian J Med Res. 2005;121(1):36-8.

Gubler DJ. Epidemic Dengue/Dengue Haemorrhagic Fever: A Global Public Health Problem in the 21st Century. Dengue bulletin. 1997;21:1-15.

Gubler DJ. Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem. In: Gubler DJ, Kuno G, editors. Dengue and dengue hemorrhagic fever [Internet]. London: CAB International; 1997 [cited 2019 Apr 4].p.1-22.

Bharaj P, Chahar HS, Pandey A, Diddi K, Dar L, Guleria R, et al. Concurrent infections by all four dengue virus serotypes during an outbreak of dengue in 2006 in Delhi, India. Virol J. 2008;5:1. doi:10.1186/1743-422X-5-1.

Chahar HS, Bharaj P, Dar L, Guleria R, Kabra SK, Broor S. Co-infections with chikungunya virus and dengue virus in Delhi, India. Emerging Infect Dis. 2009;15(7):1077-1080. doi:10.3201/eid1507.080638.

Mustafa MS, Rasotgi V, Jain S, Gupta V. Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control. Med J Armed Forces India. 2015;71(1):67-70. doi:10.1016/j.mjafi.2014.09.011.

Cucunawangsih, Lugito NPH. Trends of Dengue Disease Epidemiology. Virology (Auckl). 2017;8:1178122X17695836. doi:10.1177/1178122X17695836.

Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11(3):480-96.

Innis BL, Nisalak A, Nimmannitya S, Kusalerdchariya S, Chongswasdi V, Suntayakorn S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am J Trop Med Hyg. 1989;40(4):418-27.

Yamada K, Nawa M, Takasaki T, Yabe S, Kurane I. Laboratory diagnosis of dengue virus infection by reverse transcriptase polymerase chain reaction (RT-PCR) and IgM-capture enzyme-linked immunosorbent assay (ELISA). Jpn J Infect Dis. 1999;52(4):150-5.

Guzmán MG, Kourí G. Advances in dengue diagnosis. Clin Diagn Lab Immunol. 1996;3(6):621-7.

Sang RC. Dengue in Africa. In: report of the scientific working group meeting on dengue [Internet]. Geneva: WHO special programme for research and training in tropical diseases. 2007 [cited 2019 Nov 27]. p. 50-2. <http://apps.who.int/iris/bitstream/10665/69787/1/TDR_SWG_08_eng.pdf>

Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011;17(8):1349-54. doi:10.3201/eid1708.101515.

Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27(1):1-13.

Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. doi:10.1038/nature12060.

Eldin C, Gautret P, Nougairede A, Sentis M, Ninove L, Saidani N, et al. Identification of dengue type 2 virus in febrile travellers returning from Burkina Faso to France, related to an ongoing outbreak, October to November 2016. Euro Surveill. 2016;21(50):30425. doi:10.2807/1560-7917.ES.2016.21.50.30425.

Jentes ES, Robinson J, Johnson BW, Conde I, Sakouvougui Y, Iverson J, et al. Acute arboviral infections in Guinea, West Africa, 2006. Am J Trop Med Hyg. 2010;83(2):388-94. doi:10.4269/ajtmh.2010.09-0688.

Ninove L, Parola P, Baronti C, De Lamballerie X, Gautret P, Doudier B, et al. Dengue virus type 3 infection in traveler returning from west Africa. Emerg Infect Dis. 2009;15(11):1871-2. doi:10.3201/eid1511.081736.

World Health Organization. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control : New Edition [Internet]. Geneva: World Health Organization; 2009 [cited 2019 Apr 4]. <https://apps.who.int/iris/handle/10665/44188>

World Health Organization. Dengue in Africa: emergence of DENV-3, Côte d’Ivoire, 2008. Wkly Epidemiol Rec. 2009;84(11-12):85-8. English, French.

Fofana D, Beugré JMV, Yao-Acapovi GL, Lendzele SS. Risk of Dengue Transmission in Cocody (Abidjan, Ivory Coast). J Parasitol Res. 2019 Jan 14; 2019:4914137. doi:10.1155/2019/4914137.

Simo FBN, Bigna JJ, Kenmoe S, Ndangang MS, Temfack E, Moundipa PF, et al. Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies. Sci Rep. 2019;9(1):13626. doi:10.1038/s41598-019-50135-x.

Amoako N, Duodu S, Dennis FE, Bonney JHK, Asante KP, Ameh J, et al. Detection of Dengue Virus among Children with Suspected Malaria, Accra, Ghana. Emerg Infect Dis. 2018;24(8):1544-7. doi:10.3201/eid2408.180341.

Ridde V, Agier I, Bonnet E, Carabali M, Dabiré KR, Fournet F, et al. Presence of three dengue serotypes in Ouagadougou (Burkina Faso): research and public health implications. Infect Dis Poverty. 2016;5:23. doi:10.1186/s40249-016-0120-2.

Collenberg E, Ouedraogo T, Ganamé J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: A comparative analysis. J Med Virol. 2006;78(5):683-92. doi:10.1002/jmv.20593.

Sanou AS, Dirlikov E, Sondo KA, Kagoné TS, Yameogo I, Sow HE, et al. Building Laboratory-Based Arbovirus Sentinel Surveillance Capacity During an Ongoing Dengue Outbreak, Burkina Faso, 2017. Health Secur. 2018;16(S1):S103-10. doi:10.1089/hs.2018.0048.

Sow A, Loucoubar C, Diallo D, Faye O, Ndiaye Y, Senghor CS, et al. Concurrent malaria and arbovirus infections in Kedougou, southeastern Senegal. Malar J. 2016;15(1):47. doi:10.1186/s12936-016-1100-5.

Monlun E, Zeller H, Le Guenno B, Traoré-Lamizana M, Hervy JP, Adam F, et al. [Surveillance of the circulation of arbovirus of medical interest in the region of eastern Senegal]. Bull Soc Pathol Exot. 1993;86(1):21-28. French.

World Health Organization. Diagnostic En Laboratoire de La Fièvre Jaune En Afrique: Lignes Directrices Provisoires. Geneva: World Health Organizaiton; 7 p. French.

Fagbami AH, Onoja AB. Dengue haemorrhagic fever: An emerging disease in Nigeria, West Africa. J Infect Public Health. 2018;11(6):757-62. doi:10.1016/j.jiph.2018.04.014.

Onoja AB, Adeniji JA, Olaleye OD. High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria. Acta Trop. 2016;160:39-43. doi:10.1016/j.actatropica.2016.04.007.

Kolawole OM, Seriki AA, Irekeola AA, Bello KE, Adeyemi OO. Dengue virus and malaria concurrent infection among febrile subjects within Ilorin metropolis, Nigeria. J Med Virol. 2017;89(8):1347-53. doi:10.1002/jmv.24788.

Huhtamo E, Uzcátegui NY, Siikamäki H, Saarinen A, Piiparinen H, Vaheri A, et al. Molecular epidemiology of dengue virus strains from Finnish travelers. Emerg Infect Dis. 2008;14(1):80-3.

Raut CG, Rao NM, Sinha DP, Hanumaiah H, Manjunatha MJ. Chikungunya, dengue, and malaria co-infection after travel to Nigeria, India. Emerg Infect Dis. 2015;21(5):908-9. doi:10.3201/eid2105.141804.

Gregianini TS, Tumioto-Giannini GL, Favreto C, Plentz LC, Ikuta N, da Veiga ABG. Dengue in Rio Grande do Sul, Brazil: 2014 to 2016. Rev Med Virol. 2018;28(1):e1960. doi:10.1002/rmv.1960.

Gupta E, Mohan S, Bajpai M, Choudhary A, Singh G. Circulation of Dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after Dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. J Vector Borne Dis. 2012;49(2):82-5.

Sharp TM, Hunsperger E, Santiago GA, Muñoz-Jordan JL, Santiago LM, Rivera A, et al. Virus-Specific Differences in Rates of Disease during the 2010 Dengue Epidemic in Puerto Rico. PLoS Negl Trop Dis. 2013;7(4):e2159. doi:10.1371/journal.pntd.0002159.

Teixeira MG, Siqueira, JB, Ferreira GLC, Bricks L, Joint G. Epidemiological Trends of Dengue Disease in Brazil (2000–2010): A Systematic Literature Search and Analysis. PLoS Negl Trop Dis. 2013;7(12):e2520. doi:10.1371/journal.pntd.0002520.

Villar LA, Rojas DP, Besada-Lombana S, Sarti E. Epidemiological Trends of Dengue Disease in Colombia (2000-2011): A Systematic Review. PLoS Negl Trop Dis. 2015;9(3): e0003499. doi:10.1371/journal.pntd.0003499.

Yeh CY, Chen PL, Chuang KT, Shu YC, Chien YW, Perng GC, et al. Symptoms associated with adverse dengue fever prognoses at the time of reporting in the 2015 dengue outbreak in Taiwan. PLoS Negl Trop Dis. 2017;11(12):e0006091. doi:10.1371/journal.pntd.0006091.

Chakravarti A, Kumaria R. Eco-epidemiological analysis of dengue infection during an outbreak of dengue fever, India. Virol J. 2005;2(1):32.

Thu HM, Lowry K, Myint TT, Shwe TN, Han AM, Khin KK, et al. Myanmar dengue outbreak associated with displacement of serotypes 2, 3, and 4 by dengue 1. Emerg Infect Dis. 2004;10(4):593-7. doi:10.3201/eid1004.030216.

Baba MM, Saron MF, Vorndam AV, Adeniji JA, Diop O, Olaleye D. Dengue virus infections in patients suspected of malaria/typhoid in Nigeria. J Am Sci. 2009;5(5):129-34.

Li CF, Lim TW, Han LL, Fang R. Rainfall, abundance of Aedes aegypti and dengue infection in Selangor, Malaysia. Southeast Asian J Trop Med Public Health. 1985;16(4):560-8.

Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16. doi:10.1038/nrmicro2460.

Rossi SL, Nasar F, Cardosa J, Mayer SV, Tesh RB, Hanley KA, et al. Genetic and phenotypic characterization of sylvatic dengue virus type 4 strains. Virology. 2012;423(1):58-67. doi:10.1016/j.virol.2011.11.018.

Centers for Disease Control and Prevention. Trioplex Real-Time RT-PCR Assay [Internet]. US: Centers for Disease Control and Prevention; 2017 Apr 6 [cited 2019 Apr 26]. 66 p. <https://www.cdc.gov/zika/pdfs/trioplex-real-time-rt-pcr-assay-instructions-for-use.pdf>

Santiago GA, Vázquez J, Courtney S, Matías KY, Andersen LE, Colón C, et al. Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses. Nat Commun. 2018;9(1):1391. doi:10.1038/s41467-018-03772-1.

Ito M, Takasaki T, Yamada KI, Nerome R, Tajima S, Kurane I. Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol. 2004;42(12):5935-7. doi:10.1128/JCM.42.12.5935-5937.2004.

Published

2021-09-30

How to Cite

Sylla, Y., Diane, M. K., Adjogoua, V. E., Kadjo, H., & Dosso, M. (2021). Dengue Outbreaks in Abidjan: Seroprevalence and Cocirculating of Three Serotypes in 2017. Outbreak, Surveillance, Investigation & Response (OSIR) Journal, 14(3), 94–103. https://doi.org/10.59096/osir.v14i3.262527

Issue

Section

Original article